Is the National Veterinary Care share price in the buy zone?

National Veterinary Care Ltd (ASX: NVL) is a provider of veterinary services in Australia and New Zealand. Is it in the buy zone on the ASX 200?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

National Veterinary Care Ltd (ASX: NVL) is a provider of veterinary services in Australia and New Zealand. It operates a portfolio of general practice clinics, and partners with independent clinics to form a network of 98 integrated veterinary businesses. It aims to achieve growth through acquisition, as well as organic growth through business initiatives such as its 'Best for Pet' loyalty program.

Recent performance

After a difficult few months, investors in National Veterinary Care were eager to track the performance of its recent Pet Doctors acquisition in New Zealand. The Pet Doctors Group, acquired in October 2018, consists of 23 clinics and 2 training facilities, and represents NVL's largest acquisition since listing on the ASX in 2015.

In February, the company posted revenue of growth of 30% to $54.1 million for the half year, and an underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of $8.2 million (up 29.9% compared to FY2018H1). Despite this, net profit after tax (NPAT) was down 19.9% due to acquisition costs, as well as one-off profits reported in the prior year. Shares in NVL have remained stable since the announcement.

Growth by acquisition

One of National Veterinary Care's key growth strategies is through the acquisition and integration of veterinary clinics into its network. Despite consecutively strong periods of headline (revenue) growth, the company's shrinking EBITDA margins represent a concern to overall profitability.

While the company states the synergistic and procurement benefits from optimising economies of scale, the company's shrinking EBITDA margin (underlying) from 15.7% to 15% suggest that they continue to face challenges in integrating these businesses. Organic revenue growth (on a like-for-like basis) for the period of 2.9% also appears to be on the lower end of expectations.     

Outlook

National Veterinary Care expects to achieve an underlying revenue growth of 40% above their FY2018 figures and maintain underlying EBITDA margins of between 14.5%–15%. The Best for Pet Wellness Program has been implemented in 81 clinics, and aims to bring in an additional 8,000 members (35% growth) by the end of the calendar year. If the company is able to achieve this growth, it can provide a means to distinguish itself from competitors and strengthen the National Veterinary Care brand.

Foolish takeaway

At the current price-to-earnings multiple of 18, it's easy to see why some investors consider the growth potential in National Veterinary Care to be good value. The main concern is whether its recent acquisitions will bring in the expected growth to justify its cost. At this stage, I would not be a buyer of National Veterinary Limited shares until the company can show improving margins, and the synergistic benefits of these acquisitions making a material impact on earnings.

Saran Likitkunawong has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of NATVETCARE FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »